NSIGHT: Sequencing of Newborn Blood Spot DNA to Improve and Expand Newborn Screening
Institution: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
FOA Number: PA-18-591
The purpose of the Newborn Sequencing In Genomic medicine and public HealTh (NSIGHT) program is to explore, in a limited but deliberate manner, the implications, challenges and opportunities associated with the possible use of genomic sequence information in the newborn period. Funds will be used to stimulate research in three component projects specifically applicable to newborn screening:
1) Acquisition and analysis of genomic datasets that expand considerably the scale of data available for analysis in the newborn period.
2) Clinical research that will advance understanding of specific disorders identifiable via newborn screening through promising new DNA-based analysis.
3) Research related to the ethical, legal and social implications (ELSI) of the possible implementation of genomic sequencing of newborns.
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Sep 5, 2013
Aug 31, 2018